Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature

References

• CortiMCRigonCEpidemiology of osteoarthritis: prevalence, risk factors and functional impactAging Clin Exp Res200315535936314703001
   PubMed Web of Science ®Google Scholar
• ZhangYJordanJMEpidemiology of osteoarthritisClin Geriatr Med201026335536920699159
   PubMed Web of Science ®Google Scholar
• BreedveldFCOsteoarthritis – the impact of a serious diseaseRheumatology (Oxford)200443Suppl 1i4i814752169
   PubMed Web of Science ®Google Scholar
• LawrenceRCFelsonDTHelmickCGEstimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part IIArthritis Rheum2008581263518163497
   PubMed Web of Science ®Google Scholar
• AbramsonSBAtturMDevelopments in the scientific understanding of osteoarthritisArthritis Res Ther200911322719519925
   PubMed Web of Science ®Google Scholar
• NukiGOsteoarthritis: a problem of joint failureZ Rheumatol199958314214710441841
   PubMed Web of Science ®Google Scholar
• LoeserRFAging and osteoarthritisCurr Opin Rheumatol201123549249621709557
   PubMed Web of Science ®Google Scholar
• McDonoughCMJetteAMThe contribution of osteoarthritis to functional limitations and disabilityClin Geriatr Med201026338739920699161
   PubMed Web of Science ®Google Scholar
• HawkerGAStewartLFrenchMRUnderstanding the pain experience in hip and knee osteoarthritis – an OARSI/OMERACT initiativeOsteoarthritis Cartilage200816441542218296075
   PubMed Web of Science ®Google Scholar
• American College of Rheumatology Subcommittee on Osteoarthritis GuidelinesRecommendations for the medical management of osteoarthritis of the hip and knee: 2000 updateArthritis Rheum20004391905191511014340
   PubMed Web of Science ®Google Scholar
• SeedSMDunicanKCLynchAMTreatment options for osteoarthritis: considerations for older adultsHosp Pract (Minneap)2011391627321441760
   PubMedGoogle Scholar
• ManekNJLaneNEOsteoarthritis: current concepts in diagnosis and managementAm Fam Physician20006161795180410750883
   PubMed Web of Science ®Google Scholar
• ZhangWMoskowitzRWNukiGOARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidenceOsteoarthritis Cartilage2007159981100017719803
   PubMed Web of Science ®Google Scholar
• GibofskyABarkinRLChronic pain of osteoarthritis: considerations for selecting an extended-release opioid analgesicAm J Ther200815324125518496262
   PubMed Web of Science ®Google Scholar
• CaseJPBaliunasAJBlockJALack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodiumArch Intern Med2003163216917812546607
   PubMedGoogle Scholar
• TowheedTEMaxwellLJuddMGCattonMHochbergMCWellsGAcetaminophen for osteoarthritisCochrane Database Syst Rev20061CD00425716437479
   PubMed Web of Science ®Google Scholar
• ZhangWJonesADohertyMDoes paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trialsAnn Rheum Dis200463890190715020311
   PubMed Web of Science ®Google Scholar
• BjordalJMLjunggrenAEKlovningASlordalLNon-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trialsBMJ20043297478131715561731
   PubMed Web of Science ®Google Scholar
• OngCKSLirkPTanCHSeymourRAAn evidence-based update on nonsteroidal anti-inflammatory drugsClin Med Res200751193417456832
   PubMedGoogle Scholar
• SmalleyWERayWADaughertyJRGriffinMRNonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly personsAm J Epidemiol199514165395457900721
   PubMed Web of Science ®Google Scholar
• BlantzRCAcetaminophen: acute and chronic effects on renal functionAm J Kidney Dis1996281 Suppl 1S3S68669426
   PubMed Web of Science ®Google Scholar
• BrandtKDThe role of analgesics in the management of osteoarthritis painAm J Ther200072759011319576
   PubMedGoogle Scholar
• KatzWAUse of nonopioid analgesics and adjunctive agents in the management of pain in rheumatic diseasesCurr Opin Rheumatol2002141637111790999
   PubMed Web of Science ®Google Scholar
• MamdaniMRochonPAJuurlinkDNObservational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugsBMJ2002325736562412242172
   PubMed Web of Science ®Google Scholar
• TaylorRJrPergolizziJVJrRaffaRBAcetaminophen (paracetamol): properties, clinical uses, and adverse effectsJavaherianALatifpourPAcetaminophen: Properties, Clinical Uses and Adverse EffectsHauppauge, NYNova Science Publishers Inc2012In press
   Google Scholar
• McHughesMLipmanAGManaging osteoarthritis pain when your patient fails simple analgesics and NSAIDs and is not a candidate for surgeryCurr Rheumatol Rep200681222916515761
   PubMedGoogle Scholar
• HowesFBuchbinderRWinzenbergTBOpioids for osteoarthritis? Weighing benefits and risks: a Cochrane Musculoskeletal Group reviewJ Fam Pract201160420621221472151
   PubMed Web of Science ®Google Scholar
• PergolizziJBogerRHBuddKOpioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone)Pain Pract20088428731318503626
   PubMedGoogle Scholar
• American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older PersonsPharmacological management of persistent pain in older personsPain Med20091061062108319744205
   PubMed Web of Science ®Google Scholar
• NicholsonBResponsible prescribing of opioids for the management of chronic painDrugs2003631173212487620
   PubMed Web of Science ®Google Scholar
• HariharanJLambGCNeunerJMLong-term opioid contract use for chronic pain management in primary care practice. A five year experienceJ Gen Intern Med200722448549017372797
   PubMed Web of Science ®Google Scholar
• McCarbergBHBarkinRLLong-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesiaAm J Ther20018318118611344385
   PubMedGoogle Scholar
• SloanPBabulNExtended-release opioids for the management of chronic non-malignant painExpert Opin Drug Deliv20063448949716822224
   PubMedGoogle Scholar
• HeiskanenTKalsoEControlled-release oxycodone and morphine in cancer related painPain199773137459414055
   PubMed Web of Science ®Google Scholar
• BrueraEBelzileMPituskinERandomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer painJ Clin Oncol19981610322232299779695
   PubMed Web of Science ®Google Scholar
• Mucci-LoRussoPBermanBSSilbersteinPTControlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group studyEur J Pain19982323924915102384
   PubMed Web of Science ®Google Scholar
• StambaughJERederRFStambaughMDStambaughHDavisMDouble- blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patientsJ Clin Pharmacol200141550050611361046
   PubMed Web of Science ®Google Scholar
• KoizumiWTomaHWatanabeKEfficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tabletsJpn J Clin Oncol2004341060861415591459
   PubMed Web of Science ®Google Scholar
• NicholsonBRossESasakiJWeilARandomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant painCurr Med Res Opin20062281503151416870075
   PubMed Web of Science ®Google Scholar
• FurlanADSandovalJAMailis-GagnonATunksEOpioids for chronic noncancer pain: a meta-analysis of effectiveness and side effectsCMAJ2006174111589159416717269
   PubMed Web of Science ®Google Scholar
• CaldwellJRHaleMEBoydRETreatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trialJ Rheumatol199926486286910229408
   PubMed Web of Science ®Google Scholar
• RothSHFleischmannRMBurchFXAround-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluationArch Intern Med2000160685386010737286
   PubMedGoogle Scholar
• MarkensonJACroftJZhangPGRichardsPTreatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trialClin J Pain200521652453516215338
   PubMed Web of Science ®Google Scholar
• SaariTIIhmsenHNeuvonenPJOlkkolaKTSchwildenHOxycodone clearance is markedly reduced with advancing age: a population pharmacokinetic studyBr J Anaesth2012108349149822201184
   PubMed Web of Science ®Google Scholar
• MatsumotoAKBabulNAhdiehHOxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trialPain Med20056535736616266356
   PubMed Web of Science ®Google Scholar
• HaleMTudorICKhannaSThipphawongJEfficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysisClin Ther200729587488817697906
   PubMed Web of Science ®Google Scholar
• GajriaKKosinskiMScheinJKavanaghSDuboisDHealth-related quality-of-life outcomes in patients treated with push-pull OROS hydromorphone versus extended-release oxycodone for chronic hip or knee osteoarthritis pain: a randomized, open-label, parallel-group, multicenter studyPatient20081322323822272928
   PubMedGoogle Scholar
• AfilaloMEtropolskiMSKuperwasserBEfficacy and safety of tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III studyClin Drug Investig2010308489505
   PubMed Web of Science ®Google Scholar
• WildJEGrondSKuperwasserBLong-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis painPain Pract201010541642720602712
   PubMed Web of Science ®Google Scholar
• LangeBKuperwasserBOkamotoAEfficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back painAdv Ther201027638139920556560
   PubMed Web of Science ®Google Scholar
• FriedmannNKlutzaritzVWebsterLLong-term safety of Remoxy® (extended-release oxycodone) in patients with moderate to severe chronic osteoarthritis or low back painPain Med201112575576021481168
   PubMed Web of Science ®Google Scholar
• ChouRHuffmanLHNonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guidelineAnn Intern Med2007147749250417909210
   PubMed Web of Science ®Google Scholar
• ChouRFanciulloGJFinePGClinical guidelines for the use of chronic opioid therapy in chronic noncancer painJ Pain200910211313019187889
   PubMed Web of Science ®Google Scholar
• PergolizziJVJrLabhsetwarSAPuenpatomRAJooSBen-JosephRHSummersKHPrevalence of exposure to potential CYP450 pharmacokinetic drug–drug interactions among patients with chronic low back pain taking opioidsPain Pract201111323023920807350
   PubMed Web of Science ®Google Scholar
• GalerBSCoyleNPasternakGWPortenoyRKIndividual variability in the response to different opioids: report of five casesPain199249187911375728
   PubMed Web of Science ®Google Scholar
• OxyContin^® (oxycodone hydrochloride controlled-release) tablets [package insert.]Stamford, CTPurdue Pharma LP2010
   Google Scholar